Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norah Terrault

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Clinical Liver Disease|May 2, 2019
Estrategias para el tratamiento de pacientes con infección por el virus de la hepatitis B sometidos a terapia inmunomoduladora: ¿es suficiente usar lamivudina?Norah Terrault
Hepatology (Baltimore, Md.)|May 13, 2015
Difficult-to-cure populations with chronic hepatitis C: Vanishing in the direct-acting antiviral era?Norah Terrault
The American Journal of Gastroenterology|June 6, 2013
Prophylaxis in HBV-infected liver transplant patients: end of the HBIG era?Norah Terrault
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
Liver transplantation in the setting of chronic HCVNorah Terrault
The Journal of Infectious Diseases|September 22, 2023
Down-Classification of Hepatitis C Virus Diagnostics: Implications for Screening and DiagnosisNorah Terrault
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 17, 2025
Reframing hepatitis B prophylaxis in recipients of liver transplant: Time to focus on cureNorah Terrault
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2018
Is Low Level Viremia Acceptable During Antiviral Therapy of Patients With HBV Infection and Decompensated Cirrhosis?Norah Terrault
The New England Journal of Medicine|June 6, 2024
Treatment of Hepatitis D - A Future Role for Combination TherapyNorah Terrault
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 7, 2002
Motion - the available treatments for hepatitis C are cost effective: arguments for the motionNorah Terrault
Clinical Liver Disease|May 2, 2019
Management strategies for hepatitis B-infected patients undergoing immunomodulatory therapy: Is lamivudine enough?Norah Terrault
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Clinical Liver Disease|May 2, 2019
Estrategias para el tratamiento de pacientes con infección por el virus de la hepatitis B sometidos a terapia inmunomoduladora: ¿es suficiente usar lamivudina?Norah Terrault
Hepatology (Baltimore, Md.)|May 13, 2015
Difficult-to-cure populations with chronic hepatitis C: Vanishing in the direct-acting antiviral era?Norah Terrault
The American Journal of Gastroenterology|June 6, 2013
Prophylaxis in HBV-infected liver transplant patients: end of the HBIG era?Norah Terrault
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
Liver transplantation in the setting of chronic HCVNorah Terrault
The Journal of Infectious Diseases|September 22, 2023
Down-Classification of Hepatitis C Virus Diagnostics: Implications for Screening and DiagnosisNorah Terrault
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 17, 2025
Reframing hepatitis B prophylaxis in recipients of liver transplant: Time to focus on cureNorah Terrault
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2018
Is Low Level Viremia Acceptable During Antiviral Therapy of Patients With HBV Infection and Decompensated Cirrhosis?Norah Terrault
The New England Journal of Medicine|June 6, 2024
Treatment of Hepatitis D - A Future Role for Combination TherapyNorah Terrault
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 7, 2002
Motion - the available treatments for hepatitis C are cost effective: arguments for the motionNorah Terrault
Clinical Liver Disease|May 2, 2019
Management strategies for hepatitis B-infected patients undergoing immunomodulatory therapy: Is lamivudine enough?Norah Terrault
Pageof 17